Malignant episodic (or "breakthrough") pain is a common feature of cancer pain that can have a negative impact on quality of life for both the patient and carer. It is characterized by a periodic increase in pain over background cancer pain and can be both severe in intensity and rapid inonset. Some patients who experience breakthrough pain are unresponsive to treatment and can pose a clinical challenge for physicians. This volume contains chapters detailing strategies for the assessment, management and treatment of breakthrough pain. The use of opioids for the treatment of breakthrough pain is thoroughly explored, with material covering oral, nasal and other routes for opioid administration. Furthermore, the bookincludes chapters on non-opioid pharamological treatments, as well as non-pharamological interventions. New additions to the second edition include a revised chapter on the general management of breakthrough pain and an up-to-date section on the latest data on intranasal fentanyl products. These updates ensure that Cancer-related Breakthrough Pain continues to be an invaluable resource for specialistsand trainees in the field of pain management, as well as being a quick reference guide for GPs, specialist nurses, and other medical professionals.